Ignite Creation Date:
2024-05-06 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 12:51 PM
Study NCT ID:
NCT03631472
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-05-09
First Post:
2018-08-13
Brief Title:
Gala Early Feasibility Study of RheOx
Sponsor:
Gala Therapeutics Inc
Organization:
Gala Therapeutics Inc
Organization Data
Organization:
Gala Therapeutics Inc
Class:
INDUSTRY
Study ID:
CS003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gala Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None